All lobbying filings
G2G CONSULTING
G2G CONSULTING filed a Q3 report for CELMATIX on October 14, 2025, reporting no lobbying activity.
Lobbying for CELMATIX · Womens health biotech focused on ovarian biology
Filing · LD-2 quarterly report
Q3 reportNo activity
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 14, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New York
Lobbying activity
0
No itemized activity in this filing.